| Trial Identifier: | D7960C00001 |
| Sponsor: | AstraZeneca |
| Collaborator: |
Parexel
|
| NCTID:: | NCT05384262 |
| Start Date: | May 2022 |
| Primary Completion Date: | June 2024 |
| Study Completion Date: | June 2024 |
| Condition: | Heart, Blood & Circulatory - Other |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| Chinese Translation | |
| English Version | |
| Japanese Translation |
| Country | Location |
|---|---|
| GB | Harrow, GB, HA1 3UJ |
| US, CA | Glendale, CA, US, 91206 |
| US, MD | Brooklyn, MD, US, 21225 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2026 Pharma Intelligence UK Limited (Citeline), a Norstella company